MicroRNAs regulating meis1 expression and inducing cardiomyocyte proliferation

Area of Science:

• Cardiovascular Biology
• Molecular Cardiology
• Regenerative Medicine

Background:

• Cardiovascular disease remains a leading cause of death, with limited myocardial tissue regeneration post-injury due to adult cardiomyocyte proliferation arrest.
• Neonatal cardiomyocytes proliferate, but adult cardiomyocytes lose this ability, hindering heart repair.
• Meis1 has been identified as a key regulator of the cardiomyocyte cell cycle.

Purpose of the Study:

• To identify microRNAs (miRNAs) that can induce proliferation in adult cardiomyocytes.
• To investigate the role of Meis1 in miRNA-mediated cardiomyocyte proliferation.
• To explore potential therapeutic targets for cardiac regeneration.

Main Methods:

• In-silico analysis and luciferase assays to identify miRNA binding sites on the Meis1 3'UTR.
• Treatment of adult cardiomyocytes with specific miRNAs (miR-548c-3p, miR-509-3p, miR-23b-3p) and siRNA against Meis1.
• Assessment of cardiomyocyte proliferation and downstream target regulation.

Main Results:

• Three miRNAs (miR-548c-3p, miR-509-3p, miR-23b-3p) were found to have binding sites on the Meis1 3'UTR.
• These miRNAs significantly increased adult cardiomyocyte proliferation via translational inhibition of Meis1.
• miRNA treatment and Meis1 inhibition led to increased cardiomyocyte numbers and affected cell-cycle regulators.

Conclusions:

• Specific miRNAs can induce proliferation in adult cardiomyocytes by targeting Meis1.
• This mechanism of Meis1 inhibition by miRNAs regulates cell-cycle progression in cardiomyocytes.
• Further research into these miRNAs could reveal new therapeutic strategies for cardiac regeneration.